Scalper1 News
Everyone gets sick, and drastic health problems call for more drastic treatment. That’s partly why several top-rated biotech stocks in today’s IBD 50 list have held up well despite recent market pressue. Alexion Pharmaceuticals (ALXN), the fourth stock in today’s screen, develops treatments for neurological and other disorders. The company has two years of strong EPS and sales gains under its belt, driven by Soliris, its blockbuster drug that Scalper1 News
Scalper1 News